-
Product Insights
NewPolycystic Ovarian Syndrome – Drugs In Development, 2024
Empower your strategies with our Polycystic Ovarian Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Polycystic ovarian syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms include menstrual abnormality, acne, thinning hair on the scalp, weight gain, excess androgen, and polycystic ovaries. The main risk factor for PCOS is a family history. Other factors include type 2 diabetes and heart disease. Treatment includes hormone therapy. The Polycystic Ovarian Syndrome drugs in development...
-
Product Insights
NewEncephalomyelitis – Drugs In Development, 2024
Empower your strategies with our Encephalomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Encephalomyelitis is an inflammation of the brain and spinal cord. Encephalomyelitis can be caused by a variety of conditions that lead to irritation of the brain and spinal cord. Among the common causes of encephalomyelitis are viruses which infect the nervous tissues. Signs and symptoms include neck stiffness, headache, and fever. Treatment includes antibiotics and corticosteroids. The Encephalomyelitis drugs in development market research...
-
Product Insights
NewArrhythmias – Drugs In Development, 2024
Empower your strategies with our Arrhythmias – Drugs In Development, 2024 report and make more profitable business decisions. An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. Signs and symptoms include anxiety, weakness, dizziness, and light-headedness; fainting or nearly fainting; sweating; shortness of breath; and chest pain. Treatment includes anti-arrhythmics and anticoagulants. The Arrhythmias drugs in development market research report provide...
-
Product Insights
NewOvarian Disease – Drugs In Development, 2024
Empower your strategies with our Ovarian Disease – Drugs In Development, 2024 report and make more profitable business decisions. Ovarian disease is a term for various conditions that affect the ovaries, which are the female reproductive organs that produce eggs and hormones. The most common ovarian diseases include polycystic ovary syndrome (PCOS), a hormonal disorder that causes irregular periods, excess androgen, and multiple cysts on the ovaries. PCOS can affect fertility and increase the risk of diabetes and heart disease. Another...
-
Product Insights
NewColitis – Drugs In Development, 2024
Empower your strategies with our Colitis – Drugs In Development, 2024 report and make more profitable business decisions. Colitis is swelling (inflammation) of the large intestine (colon). Colitis can have many different causes, including infections with a virus or parasite or bacterial food poisoning; inflammatory disorders, namelsy ulcerative colitis and Crohn's disease; lack of blood flow (ischemic colitis); or past radiation exposure to the large bowel. Symptoms can include abdominal pain, bloating, bloody stools, chills, dehydration, diarrhea, and fever. Treatment includes...
-
Product Insights
NewRetinal Degeneration – Drugs In Development, 2024
Empower your strategies with our Retinal Degeneration – Drugs In Development, 2024 report and make more profitable business decisions. Retinal degeneration refers to a group of diseases that cause progressive damage to the cells of the retina, the light-sensitive tissue at the back of the eye crucial for vision. These conditions lead to a gradual loss of vision, which can range from mild to severe and can eventually result in blindness. There are several types of retinal degenerative diseases, including: Retinitis...
-
Product Insights
NewEndometriosis – Drugs In Development, 2024
Empower your strategies with our Endometriosis – Drugs In Development, 2024 report and make more profitable business decisions. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility, and abnormal bleeding. Risk factors include age, uterine abnormalities, history of pelvic infection, and family history. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), birth control pills, and progestins. The Endometriosis drugs in development market...
-
Product Insights
NewArteriosclerosis – Drugs In Development, 2024
Empower your strategies with our Arteriosclerosis – Drugs In Development, 2024 report and make more profitable business decisions. Arteriosclerosis refers to the thickening and hardening of arteries due to plaque buildup, limiting blood flow. Atherosclerosis, a common form, involves cholesterol and other substances accumulating in arterial walls, narrowing them. This condition heightens the risk of heart disease, stroke, and peripheral artery disease. Factors like high blood pressure, cholesterol, smoking, diabetes, and obesity contribute. Management involves lifestyle changes—such as a healthy diet...
-
Product Insights
NewAtherosclerosis – Drugs In Development, 2024
Empower your strategies with our Atherosclerosis – Drugs In Development, 2024 report and make more profitable business decisions. Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive buildup of plaque around the artery wall. The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. Symptoms of atherosclerosis are chest pain (angina); pain in the leg, arm, and anywhere else that an artery is blocked; shortness of breath;...
-
Product Insights
NewMyocardial Infarction – Drugs In Development, 2024
Empower your strategies with our Myocardial Infarction – Drugs In Development, 2024 report and make more profitable business decisions. Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest; jaw pain, toothache, or headache; shortness of breath; nausea, vomiting, and/or general epigastric discomfort; sweating, heartburn and/or indigestion; arm pain; upper back pain; and general malaise (vague feeling of illness). The Myocardial Infarction drugs in development market research report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.